FDA Inspection 1064287 — Catalent U.K. Swindon Zydis Limited
The FDA completed an inspection of Catalent U.K. Swindon Zydis Limited on July 26, 2018 in Swindon. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 26, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Swindon (United Kingdom)